Sung Yong Oh

机构：Korea University Medical Center, Dong-A University Hospital, Dong-A University · ORCID：0000-0002-8321-4113

发表论文 398 篇 · 总被引 8829 次 · h-index 44

代表论文

• Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma (2025 · Journal of Clinical Oncology · 被引 56)
• Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (2025 · Nature Cancer · 被引 52)
• Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study (2025 · Journal of Clinical Oncology · 被引 44)
• Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma (2025 · Blood · 被引 8)
• Nivolumab Plus Chemotherapy versus Placebo Plus Chemotherapy in Korean Patients with HER2-Negative, Untreated, Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer: Subgroup Analysis of a Randomized, Multicenter, Double-Blind Phase 3 Trial (ATTRACTION-4) (2025 · Cancer Research and Treatment · 被引 3)
• frontMIND: Phase 3 study of tafasitamab (Tafa) plus lenalidomide (Len) and R-CHOP for patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL). (2026 · Journal of Clinical Oncology · 被引 2)